Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Dr David Hodgson

Res. Fellow in Infectious Dis. Modelling

United Kingdom

Jump to: Affiliations Publications

Affiliations
Department of Infectious Disease Epidemiology and Dynamics
Faculty of Epidemiology and Population Health

Selected Publications
Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines
HODGSON, D; Liu, Y; Carolan, L; Mahanty, S; Subbarao, K; Sullivan, SG; Fox, A; KUCHARSKI, A;
2025
Frontiers in Immunology
serojump: A Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological data.
HODGSON, D; Hay, J; Jarju, S; JOBE, D; Wenlock, R; De Silva, TI; Kucharski, AJ;
2025
medRxiv
Antibody responses against influenza A decline with successive years of annual influenza vaccination.
Sullivan, SG; Khvorov, A; Carolan, L; Dowson, L; Hadiprodjo, AJ; Sánchez-Ovando, S; Liu, Y; Leung, VK Y; HODGSON, D; Blyth, CC; Macnish, M; Cheng, AC; Haugenauer, M; Clark, J; Dougherty, S; Macartney, K; Koirala, A; Khatami, A; Jadhav, A; Marshall, H; Riley, KE; Wark, PA B; Delahunty, C; Subbarao, K; KUCHARSKI, AJ; ... Fox, A.
2025
NPJ vaccines
Cost-effectiveness of anti-viral treatment for infants with RSV disease in the United Kingdom.
Gebrecherkos, Y; HODGSON, D;
2024
Vaccine
Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicity.
HODGSON, D; Sánchez-Ovando, S; Carolan, L; Liu, Y; Hadiprodjo, AJ; Fox, A; Sullivan, SG; KUCHARSKI, AJ;
2024
Vaccine
Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study.
Krauer, F; Guenther, F; Treskova-Schwarzbach, M; Schoenfeld, V; Koltai, M; Jit, M; HODGSON, D; Schneider, U; Wichmann, O; Harder, T; Sandmann, FG; FLASCHE, S;
2024
BMC medicine
Antibody responses against influenza A decline with successive years of annual influenza vaccination: results from an Australian Healthcare Worker cohort.
Sullivan, S; Khvorov, A; Carolan, L; Dowson, L; Hadiprodjo, J; Sánchez-Ovando, S; Liu, Y; Leung, V; HODGSON, D; Blyth, C; Macnish, M; Cheng, A; Hagenauer, M; Clark, J; Dougherty, S; Macartney, K; Koirala, A; Khatami, A; Jadhav, A; Marshall, H; Riley, K; Wark, P; Delahunty, C; Subbarao, K; Kucharski, A; ... Fox, A.
2024
Res Sq
Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829].
HODGSON, D; Wilkins, N; VAN LEEUWEN, E; Watson, CH; Crofts, J; FLASCHE, S; Jit, M; ATKINS, KE;
2024
The Lancet regional health. Europe
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.
RUSSELL, TW; Townsley, H; Hellewell, J; Gahir, J; Shawe-Taylor, M; Greenwood, D; HODGSON, D; Hobbs, A; Dowgier, G; Penn, R; SANDERSON, T; Stevenson-Leggett, P; Bazire, J; Harvey, R; Fowler, AS; Miah, M; Smith, C; Miranda, M; Bawumia, P; Mears, HV; Adams, L; Hatipoglu, E; O'Reilly, N; Warchal, S; Ambrose, K; ... KUCHARSKI, AJ.
2024
The Lancet. Infectious diseases
High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia.
Jarju, S; Wenlock, RD; Danso, M; JOBE, D; Jagne, YJ; Darboe, A; Kumado, M; Jallow, Y; Touray, M; Ceesay, EA; Gaye, H; Gaye, B; Tunkara, A; Kandeh, S; Gomes, M; Sylva, EL; Toure, F; Hornsby, H; Lindsey, BB; Nicklin, MJ; Sayers, JR; SESAY, AK; KUCHARSKI, A; HODGSON, D; KAMPMANN, B; ... DE SILVA, TI.
2024
Nature communications
See more information

Contact

United Kingdom